Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1963 1
1964 1
1968 1
1972 1
1976 1
1979 1
1986 2
1997 1
2004 1
2005 2
2006 1
2011 1
2012 1
2013 1
2014 3
2015 9
2016 7
2017 7
2018 5
2019 7
2020 4
2021 6
2022 4
2023 9
2024 4
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial.
Ospina-Tascón GA, Calderón-Tapia LE, García AF, Zarama V, Gómez-Álvarez F, Álvarez-Saa T, Pardo-Otálvaro S, Bautista-Rincón DF, Vargas MP, Aldana-Díaz JL, Marulanda Á, Gutiérrez A, Varón J, Gómez M, Ochoa ME, Escobar E, Umaña M, Díez J, Tobón GJ, Albornoz LL, Celemín Flórez CA, Ruiz GO, Cáceres EL, Reyes LF, Damiani LP, Cavalcanti AB; HiFLo-Covid Investigators. Ospina-Tascón GA, et al. JAMA. 2021 Dec 7;326(21):2161-2171. doi: 10.1001/jama.2021.20714. JAMA. 2021. PMID: 34874419 Free PMC article. Clinical Trial.
How sustainable was ancient Roman concrete?
Martinez DM, Miller SA, Monteiro PJM. Martinez DM, et al. iScience. 2025 Jul 30;28(8):113052. doi: 10.1016/j.isci.2025.113052. eCollection 2025 Aug 15. iScience. 2025. PMID: 40948561 Free PMC article.
Reply to the siren's song of anonymous web-based sampling.
Weiss MC, Hibbs JE, Buckley ME, Danese SR, Leitenberger A, Bollmann-Jenkins M, Meske S, Aliano-Ruiz KE, McHugh TW, Larson SL, Le EH, Green NL, Gilman PB, Kaklamani VG, Chlebowski RT, Martinez DM. Weiss MC, et al. Among authors: martinez dm. Cancer. 2022 May 1;128(9):1873-1874. doi: 10.1002/cncr.34099. Epub 2022 Feb 23. Cancer. 2022. PMID: 35194775 Free article. No abstract available.
Estimating 225Ac yield in thorium metal targets.
Rahmani M, Martinez DM. Rahmani M, et al. Among authors: martinez dm. Sci Rep. 2023 Sep 22;13(1):15848. doi: 10.1038/s41598-023-41687-0. Sci Rep. 2023. PMID: 37740000 Free PMC article.
Thermal modulation of skin friction at the finger pad.
Valenza A, Rykaczewski K, Martinez DM, Bianco A, Caggiari S, Worsley P, Filingeri D. Valenza A, et al. Among authors: martinez dm. J Mech Behav Biomed Mater. 2023 Oct;146:106072. doi: 10.1016/j.jmbbm.2023.106072. Epub 2023 Aug 12. J Mech Behav Biomed Mater. 2023. PMID: 37597311 Free article.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab.
Taylor KI, Lipsmeier F, Scelsi MA, Volkova-Volkmar E, Rukina D, Popp W, Lambrecht S, Anzures-Cabrera J, Summers D, Abt M, Monnet A, Kilchenmann T, Schjodt-Eriksen J, Essioux L, Kustermann T, Zago W, Svoboda H, Nikolcheva T, Postuma RB, Pagano G, Lindemann M; PASADENA Investigators; Prasinezumab Study Group. Taylor KI, et al. NPJ Digit Med. 2025 Jun 16;8(1):365. doi: 10.1038/s41746-025-01572-8. NPJ Digit Med. 2025. PMID: 40523921 Free PMC article.
Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.
Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. NPJ Parkinsons Dis. 2025 Jul 1;11(1):193. doi: 10.1038/s41531-025-01041-9. NPJ Parkinsons Dis. 2025. PMID: 40593721 Free PMC article.
Human body radiation area factors for diverse adult population.
Rykaczewski K, Bartels L, Martinez DM, Viswanathan SH. Rykaczewski K, et al. Among authors: martinez dm. Int J Biometeorol. 2022 Nov;66(11):2357-2367. doi: 10.1007/s00484-022-02362-7. Epub 2022 Sep 8. Int J Biometeorol. 2022. PMID: 36074273
78 results